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Abstract
Laparoscopic surgery is applied today worldwide to 
most digestive procedures. In some of them, such as 
cholecystectomy, Nissen’s fundoplication or obesity 
surgery, laparoscopy has become the standard in 
practice. In others, such as colon or gastric resection, 
the laparoscopic approach is frequently used and its 
usefulness is unquestionable. More complex procedures, 
such as esophageal, liver or pancreatic resections are, 
however, more infrequently performed, due to the 
high grade of skill necessary. As a result, there is less 
clinical evidence to support its implementation. In the 
recent years, robot-assisted laparoscopic surgery has 
been increasingly applied, again with little evidence 
for comparison with the conventional laparoscopic 
approach. This review will focus on the complex 
digestive procedures as well as those whose use in 
standard practice could be more controversial. Also 
novel robot-assisted procedures will be updated.
Key words: Laparoscopy; Robotic surgery; Colectomy; 
Esophagectomy; Gastrectomy; Obesity surgery; Liver 
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© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Laparoscopic surgery is increasingly used in 
the treatment of digestive diseases. New procedures 
are performed and novel technologies are applied. 
In addition, robot-assisted laparoscopic surgery has 
appeared as a useful tool for the digestive surgeon. 
The aim of this paper is to up-date the recent advances 
and scientific evidence supporting clinical practice.
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INTRODUCTION
Laparoscopic surgery has spread worldwide these 
days and many digestive procedures have become 
the standard practice. The rapid development in 
technology and improvement in surgeon skills have 
allowed that virtually every complex surgical technique, 
usually performed through open approaches, has 
been accomplished laparoscopically. Numerous reports 
favoring this approach have been published recently.
Caution interpreting literature is, however, 
necessary. There is a risk for selection and publication 
bias. Selection bias is possible because most favorable 
(in terms of location, number and tumor size) cases 
could have been operated on through a laparoscopic 
approach. Publication bias could also happen, since it 
is generally recognized a trend to report studies only 
with good outcomes and those exhibiting significant 
differences, which can lead to an overestimation of 
the laparoscopic approach. This publication bias can 
also be induced by some journal editors, who could 
prefer to publish papers with positive and spectacular 
outcomes more than negative and poor results. In 
addition, most published studies have been performed 
at large academic institutions by experienced 
surgeons, which could not reflect the current general 
practice.
Although feasibility of most laparoscopic procedures 
in general surgery has been shown, some have 
concerns about reproducibility, at least for the most 
complex techniques.
There are also concerns about costs of minimally 
invasive techniques in the era of cost containment. The 
advantage could come from shortening hospital stays 
and possibly diminishing some complications, but the 
disadvantage is more expensive surgical material and 
longer operating room times.
  All of these considerations can be applied with 
robotic-assisted surgery, a novel approach applied 
today in most surgical procedures, and this approach 
is becoming used more and more.
The scope of this review tries to update most 
digestive surgical procedures, which precludes a 
systematic review. Outstanding papers were reviewed, 
but we especially focused on most of the recent work.
MINIMALLY INVASIVE COLORECTAL 
SURGERY
Laparoscopic procedures started in 1902 when George 
Kelling, a German surgeon, used a laparoscope to 
assess the peritoneal cavity in a dog[1]. This procedure 
was followed by different studies until 1987 when 
Mouret in France performed the first video assisted 
laparoscopic cholecystectomy. In 1993 this technique 
was established by consensus as the gold standard 
for the treatment of cholelithiasis[2]. Since then, 
laparoscopy has been successfully used to perform 
fundoplications, appendectomies, splenectomies, 
nephrectomies and a long etcetera.
Colorectal cancer is the second cause of death 
in western countries[3]. Despite the progress in the 
different medical treatments and radiotherapy, surgery 
remains as the only potentially curative approach 
for this disease. The implementation of laparoscopic 
surgery in the field of colorectal surgery faced bigger 
difficulties because of the need of working in a broader 
surgical field that involved several quadrants, moving 
apart the small bowel, dissecting the retroperitoneal 
planes and removing a big sized specimen[4]. Despite 
all these difficulties, Jacobs et al[5] in 1991 reported 
the first laparoscopic sigmoidectomy for colon cancer 
starting a new era for colorectal surgery. 
The enthusiasm for laparoscopic colorectal re-
sections for cancer suffered a setback when in 1993 
Alexander et al[6] reported the first case of wound 
recurrence three months after a right colectomy for 
colon cancer. Tomita et al[4] published their experience 
in laparoscopic colorectal resections in 1999 reporting 
a 1% wound recurrence similar to the one reported 
in open surgery. We have needed more than 20 years 
in order to have clinical evidence to demonstrate the 
benefits of laparoscopic surgery over open surgery in 
the treatment of rectal tumors.
A prospective comparative study performed at the 
Barcelona Clinic Hospital comparing laparoscopic and 
open colonic resections with 219 patients with a 98 mo 
mean follow-up, demonstrated that the laparoscopic 
surgery group had a faster recovery after surgery and 
less morbidity with a longer survival and a lower local 
recurrence rate[7,8].
Several multicentric prospective randomized studies 
have shown the advantages of laparoscopic colonic 
surgery in terms of complications, postoperative 
recovery and oncological safety (COST, COLOR and 
CLASSIC)[9-11].
There is not yet enough evidence in the case of 
rectal surgery. The conclusions of many retrospective 
studies make us think that this approach will have 
several advantages but solid data is still lacking. 
Some studies such as the prospectively performed 
by Ströhlein et al[12] comparing laparoscopic and open 
surgery, conclude that the laparoscopic surgery group 
has the same oncological results, with faster recovery 
and a shorter hospital stay, finding statistically 
significant differences in mid and lower rectal tumors. 
This study presents a high conversion rate of 22%. 
Braga et al[13] published a prospective and 
randomized study with 168 patients comparing open 
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and laparoscopic surgery for rectal cancer with a 5-year 
follow-up. This study concludes that postoperative 
morbidity and postoperative stay were significantly 
lower in the laparoscopic group. Survival and local 
recurrence were similar in both groups with better 
scores in the quality of live tests in the laparoscopic 
group after the first year. Long term costs were similar 
in both groups. Conversion rate in the laparoscopic 
group was 7.5%.
In a review of the literature presented by Indar and 
Efron[14], the results of several prospective randomized 
trials were analyzed. From this review we can say that 
laparoscopic rectal surgery is safe, with good results 
in terms of morbidity, leaks and hospital stay. The 
conversion rate ranged from 3% to 29%. A higher 
conversion rate could be due to a lack of experience 
of the surgeons even though in some studies this rate 
was not reduced with a progression in the learning 
curve[15]. The factors associated with conversion in the 
CLASSIC trial[16] were a high body mass index (BMI), 
inaccessibility of the tumor, fixation of the tumor, and 
loss of definition of the surgical planes. Pugliese et al[17] 
have shown a significant increase in the anastomotic 
leak rate in the converted cases. Other alarming data 
is the increase of local recurrence rate up to 16% in 
those cases converted during laparoscopic surgery 
for rectal cancer, as shown by Ströhlein et al[12]. 
Scheidbach et al[18] presented a prospective study 
with 1409 patients with a 10-year follow-up about the 
impact of conversion in colorectal laparoscopic surgery. 
They observed statistically significant differences in 
terms of a higher blood loss, more postoperative 
complications, more anastomotic leaks and a decrease 
of the survival rate in the cases converted to open 
surgery. 
The COREAN Trial was a randomized and pro-
spective study performed by three Korean centers 
with a wide experience, recruiting 170 patients in 
the laparoscopic arm and 170 patients in the open 
group, with a 3-year follow-up. There was a very low 
conversion rate of 2% maybe because of the huge 
laparoscopic experience of these centers. There were 
no statistical difference in the oncological results in 
both groups and in the surgical specimen quality. The 
laparoscopic group showed a faster recovery with less 
need of postoperative pain-killers, a faster recovery 
of oral intake and a better quality of life 3 years after 
surgery[19].
In a meta-analysis published by Anderson et al[20] 
including 1403 cases of laparoscopic rectal surgery 
and 1577 cases of open rectal surgery, there was no 
difference in terms of survival or oncological results.
The Finnish trial published by Kellokumpu et al[21] 
comparing open surgery vs laparoscopic surgery for 
rectal cancer concluded that the laparoscopic approach 
offered a faster recovery after surgery, lower blood loss 
and a shorter in hospital stay with less complications 
in the long term. Survival and local recurrence 
were similar in both groups. Conversion rate in the 
laparoscopic group was up to 22%.
In the cohort retrospective study from Brazil, 
Melani et al[22] analyzed 84 rectal cancer patients that 
had undertaken surgery between 2000 and 2003, 
50% with a laparoscopic approach and 50% with an 
open procedure. Follow-up was longer than 5 years 
in both groups and they found no difference in terms 
of complications, survival and oncological results. No 
conversion rate data was provided and the authors 
admitted a selection bias since the study was not 
randomized. 
Park et al[23] published a comparative study of 
two groups with mid-low rectal tumors in which they 
performed ultralow intersphincteric dissection with an 
open approach vs a laparoscopic approach. Oncological 
and survival results were similar in both groups after 
a 3-year follow-up, but the authors concluded that 
the laparoscopic surgery group had less postoperative 
morbidity, a shorter hospital stay and a faster 
functional recovery.
In 2013, the COLOR Ⅱ trial results after a 3-year 
follow-up were published. 1103 patients from 30 
centers were recruited and randomized either to 
laparoscopic or open surgery[24]. The authors conclude 
that the laparoscopic group patients had less blood 
loss, a shorter time to start bowel movements and 
a shorter hospital stay, with statistically significant 
differences. No difference in specimen quality was 
observed. Postoperative morbidity and mortality were 
also similar. Conversion rate was 17% even though 
the surgical teams were selected among centers with 
experience in laparoscopic colorectal surgery.
In a recently published study[25], the authors 
analyze data from 3 randomized and controlled trials 
that compare laparoscopic vs open surgery for rectal 
cancer. The mean follow up was of 124.5 mo in the 
laparoscopic group and 136.6 mo in the open group. 
Disease free survival after a 10-year follow-up were 
similar in both groups. There was a tendency towards 
a lower local recurrence in the stage Ⅲ tumors treated 
with laparoscopic surgery. 
In summary, we can say that laparoscopic colonic 
surgery is feasible and completely comparable to 
open surgery, with advantages in postoperative 
complications and hospital stay. Rectal laparoscopic 
resection is also feasible and the studies performed to 
date suggest that short and long-term outcomes are 
comparable to open surgery.
Robotic colorectal surgery
Despite the advantages of the laparoscopic approach 
for colorectal surgery, this approach has some 
limitations such as loss of the 3D vision, limitations 
in the freedom degrees of the surgical instruments, 
the amplification of the physiological tremor and the 
“fulcrum” effect. 
The implementation of robotic technology avoids 
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helped to preserve sexual and urinary function after 
total mesorectal excision. 
Biffi et al[42], studied the blood loss during robotic 
rectal resections and reported that only one case of 
their series of 49 patients required blood transfusion, 
by contrast with patients with open surgery who 
required blood transfusion in 12 cases of 105.
Shiomi et al[43], in a study with 113 consecutive 
robotic rectal resections, 12 of them having T4 tumors, 
observed no conversion and no hospital mortality. The 
frequency of Clavien Ⅲ/Ⅳ complications was 2.7%. 
They concluded that robotic instrumentation was 
helpful in performing advanced dissections with a very 
low morbidity and conversion rates.
Robotic vs laparoscopic surgery for rectal cancer 
comparative studies
deSouza et al[44] compared the results obtained 
with robotic surgery in 36 consecutive cases against 
those obtained in 46 cases with laparoscopic assisted 
surgery using a hand port for the splenic flexure. The 
authors conclude that robotic total mesorectal excision 
is feasible and safe, and comparable with open surgery 
in terms of perioperative and anatomopathological 
results. There was a statistically significant difference 
in the tumor location, with more mid and low rectal 
tumor in the robotic group. 
Kwak et al[45] in another retrospective study 
concluded that the results of robotic surgery were 
comparable to those obtained with a laparoscopic 
group. This study was performed by a single surgeon 
with a huge experience in minimally invasive surgery 
for the treatment of rectal cancer. He recognizes 
a selection bias in this study and concludes that 
prospective, multicentric and randomized studies are 
necessary.
A very interesting study from Kang et al[46], 
compared three groups of patients with mid and low 
rectal tumors treated with either open, laparoscopic 
or robotic approach. They observed that the robotic 
group had a faster postoperative recovery with a lower 
hospital stay, less pain and better specimen quality. 
The disease free survival rate was similar in all groups 
three years after surgery. 
Fernandez et al[47], retrospectively compared a 
group of patients treated with a robotic approach vs 
a group treated with a laparoscopic approach. They 
performed a low anterior resection in all cases with 
low anastomosis. They observed no difference in blood 
loss, postoperative morbidity or surgical specimen 
quality but, nevertheless, they recognized that the 
robotic group had lower tumors with a more advanced 
disease and more chemo radiation. The conversion 
rate was 17% in the laparoscopic group and 8% in the 
robotic group. 
Patriti et al[48] performed a study comparing 29 
patients with robotic rectal resections against 37 
treated with a laparoscopic approach with a one-year 
this disadvantages and improves the ergonomics 
of the surgeon[26]. Uhrich et al[27] proved that the 
uncomfortable positions during laparoscopic surgery 
increase surgeons fatigue and iatrogenic injuries. 
The development of robotic surgery started in the 
mid-80s of the 20th century mainly focused in the 
development of tele-surgery. The FDA approved the 
use of Da Vinci system (Intuitive Surgical, Sunnyvale, 
CA, United States) in 2000, and nowadays is the only 
robotic system available for minimally invasive surgery.
The first article published about robotic colonic 
surgery using Da Vinci Surgical System was from 
Weber et al[28] reporting a right colectomy and a 
sigmoidectomy for benign diseases. At the same 
time, other authors published their first robotic colonic 
surgery case reports[29-31].
In 2004, D'Annibale et al[32] reported 53 patients 
that had undertaken robotic colonic resections. In this 
group, 22 were resections for oncological reasons. 
They concluded that the operative and postoperative 
results were similar to those obtained with conventional 
laparoscopic instruments. Braumann et al[33] published 
the first 5 robotic colonic resections performed in 
Germany in 2005. 
Pigazzi et al[34] and Hellan et al[35] published the 
first article reporting robotic rectal resections in 
2006. These authors reported the first series of 39 
consecutive resections for rectal cancer, concluding 
that this technique is safe and feasible. 
In Asia, the first robotic rectal surgery with total 
mesorectal excision was performed by Baik in June 
2006[36]. The same author published the first extended 
resection with hysterectomy[37]. Ng et al[38] reported 
the first robotic abdominoperineal resection in Hong 
Kong.
Few data are available regarding the value of 
robotic colonic resections but the results seem to be 
similar to those reported by conventional laparoscopic 
approaches[39]. No final conclusions can be made at 
this moment.
Robotic rectal resections for rectal cancer
There are not many articles regarding robotic rectal 
resections in the scientific literature. Hopefully, the 
ROLARR (Robotic vs Laparoscopic Resection for Rectal 
cancer) trial results will be available in a few months 
and will give some valuable information.
Baek et al[40] analyzed the results of 64 rectal 
resections for cancer with no operative mortality, a 
mean blood loss of 200 mL, a conversion rate of 9.4% 
and a leak rate of 7.7%. The mean of harvested lymph 
nodes was 14.5, the distal margin was 3.4 cm and the 
circumferential margin was negative in all cases. They 
found a local recurrence in 6 patients after an interval 
of 23 mo. The disease free survival rate was 73.7%.
Luca et al[41], performed a study analyzing sexual 
and urinary function in 74 patients after robotic rectal 
resections concluding that robotic instrumentation 
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follow-up. They obtained similar results in both groups 
with a higher conversion rate in the laparoscopic 
group: 7% vs 0%.
Lin et al[49], performed a meta-analysis concluding 
that robotic surgery is clearly superior in terms of 
conversion rate. Another meta-analysis of studies 
comparing robotic vs laparoscopic surgery for rectal 
cancer performed by Trastulli et al[50] suggested 
that the robotic surgery group had a statistically 
significant difference in conversion rate without 
significant differences in operation time, hospital stay, 
postoperative morbimortality or surgical specimen 
quality. The meta-analysis performed by Ortiz-Oshiro 
et al[51] had similar conclusions.
In the systematic review of the literature performed 
by Scarpinata and Aly[52] excluding the studies that 
referred to colonic resections, they suggested that 
there is evidence that robotic surgery may offer a 
better short term results, mainly in obese or male 
patients. It also may be better in those cases with 
previous radiotherapy and lower tumors. There was 
no evidence of any difference in terms of leakages, 
circumferential margins or preservation of the auto-
nomous function.
A study performed by a Taiwanese group[53], 
compared the postoperative results of 64 patients 
with ultralow anterior resection and intersphincteric 
dissection. Twenty-eight patients had undertaken a 
conventional laparoscopic approach and 36 a robotic 
approach. They found statistically significant differences 
in terms of surgical time - longer in the case of robotic 
surgery - and in the number of definitive stomas, 
which was 46.4% in the laparoscopic group vs 19.4% 
in the robotic surgery group. The authors conclude that 
this kind of procedure is feasible and safe with robotic 
instrumentation, with better functional outcomes and 
that surgical time will diminish as the experience of the 
surgeons increases.
Casillas et al[54], analyzed the results of robotic 
colorectal surgery performed in a single institution by 
a single surgeon. They compared 200 laparoscopic 
cases vs 144 robotic cases. They observed a shorter 
hospital stay and a lower complication rate in the case 
of robotic surgery. 
Park et al[55], performed a prospective study with 
217 patients that undertook minimally invasive surgery 
for rectal cancer. 133 patients had robotic surgery 
while 84 had a conventional laparoscopic approach. 
There were statistically significant differences in favor 
of the robotic approach in terms of hospital stay and 
conversion rates (0% vs 7.1%). Overall survival rate 
and disease free survival rate were similar in both 
groups with a 5-year follow-up. Saklani et al[56] have 
reported similar results in a 3-year follow up study. 
In a recently published meta-analysis, Xiong et al[57] 
made a comparative analysis between laparoscopic and 
robotic rectal surgery in terms of safety and efficacy. 
They identified 8 studies with an overall number of 
1229 patients, 554 robotic cases vs 675 laparoscopic 
cases. The authors concluded that the robotic approach 
is safe and feasible, but they did not find statistically 
significant differences in circumferential margins or in 
sexual function after surgery.
In summary, rectal robotic excision is feasible and 
safe, is comparable to laparoscopic surgery in terms of 
short and long-term outcomes, with some advantages 
such as shorter hospital stay, lower conversion 
rates and better functional results. Some particular 
conditions such as lower rectal tumors, male and/or 
obese patients or locally advanced rectal tumors may 
be indications that could benefit the most from the 
robotic approach.
Robotic colorectal surgery learning curve
The use of robotic instrumentation in rectal surgery 
requires not only training in surgical technique but 
also training in the use of the robotic system. This 
training has the specific handicap of the loss of the 
tactile feedback. The procedure is performed from a 
console far from the patient. This requires an excellent 
coordination between the surgeon and the surgical 
assistant.
The advantages that robotic technology provides 
make, for an expert surgeon in open surgery, less 
necessary the previous training in conventional laparo-
scopic surgery. The surgeon expert in conventional 
laparoscopic procedures has to make a specific training 
in robotic surgery. No differences have been observed 
in the learning curve for robotic surgery in surgeons 
with previous training in laparoscopic surgery vs those 
without that training.
Giulianotti et al[58] observed that the robotic surgery 
learning curve was short for easy procedures as suture 
knotting or instrument use. They also observed that 
the training for advanced surgical procedures required 
previous experience in open and laparoscopic surgery.
Very few studies analyze the learning curve in 
robotic surgery. Bokhari et al[59] estimated following the 
Cumulative Summation (CUSUM) technique that 50 
robotic rectal procedures are necessary for a surgeon 
to be proficient in this procedure. Sng et al[60] have 
recently published an article reporting a multiphasic 
learning curve. In the first phase (around 35 initial 
cases) the surgeon performs selected easy cases. In 
the second phase, with a worse CUSUM, the surgeon 
performs more complex cases (to 100 cases). Finally 
the surgeon enters in a consolidation phase. 
Buchs et al[61] have reported that the learning curve 
can be reduced using simulation in an animal/cadaver 
model or through the visualization of video clips or 
attending to courses.
In a recent study, Byrn et al[62] compared their 
initial 43 robotic rectal surgery cases with the following 
42 cases observing a significant reduction of surgical 
time and costs.
Other considerations concerning training are made 
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at the end of the paper.
Cost-effectiveness studies
One of the most criticized aspects of robotic colorectal 
surgery is the increase of cost per procedure. Cost 
analysis may vary depending on the criteria we use 
and the items we analyze. Rectal cancer process is 
very long and the analysis of costs of this process may 
vary a lot if we analyze just the perioperative period 
or a 5-year period including stoma cost, quality of life 
or local recurrence. The cost analysis also varies a lot 
depending on the health care system characteristics. 
There are not yet high quality articles that are con-
clusive about the cost issue.
Delaney et al[63] reported a significant increase 
of in-hospital costs with robotic colorectal surgery: 
2946 dollars per laparoscopic procedure vs 3721.5 
dollars per robotic resection. This increase was mainly 
attributed to the increase in intraoperative costs.
However Rawlings et al[64] did not find any 
statistically significant difference when they analyzed 
intraoperative, staff and surgical time costs. 
Park et al[55] compared robotic with laparoscopic 
rectal cases with 150 laparoscopic rectal cases and 
concluded that the robotic approach increased the 
perioperative costs. These authors recommended 
cost effectiveness studies including long-term results, 
oncological results and functional outcomes. Bodner et 
al[65] have reported similar results.
MINIMALLY INVASIVE 
ESOPHAGECTOMY
The esophageal cancer frequency - mainly adeno-
carcinoma - is increasing worldwide, presently being 
the 8th in the incidence ranking and 6th in mortality[66]. 
For patients with advanced loco-regional disease 
(T2-T4a and N +, stages Ⅱ and Ⅲ), controlled 
randomized trials and a large meta-analysis have shown 
a clear benefit in disease-free survival in patients treated 
with chemo-radiotherapy and surgery[67]. However, 
esophagectomy is one of the most complex procedures 
of the gastro-intestinal surgery, with a high postoperative 
morbidity and mortality, mainly of respiratory origin[68]. 
The potential advantages of minimally invasive pro-
cedures, especially regarding a decrease in pulmonary 
complications, have been studied for the last 4 
decades[69]. Minimally invasive esophagectomy (MIE) 
includes conventional pure laparoscopy/thoracoscopy, 
hybrid procedures (celiotomy/thoracotomy; celiotomy/
thoracoscopy), hand-assisted surgery and, more 
recently, robot-assisted esophagectomy. 
The first thoracoscopic esophagectomy was per-
formed in 1992 by Cuschieri[70]. Later, other experiences 
have been published: some reporting less than 5 cases 
of MIE Ivor Lewis each[71], larger series of three-field 
esophagectomy -McKeown technique such as that 
of Luketich et al[72] in 2003 with 222 patients, that of 
Palanivelu et al[73] in 2006 with 130 cases or others 
including hybrid procedures[74]. Three meta-analysis 
have compared MIE with open esophagectomy and 
find a benefit of MIE in a hospital stay, respiratory 
complications and overall morbidity[75-77]. Current 
evidences suggest that MIE is a feasible and safe 
technique with benefits in the short term. As a result, 
indications have been expanded from the Barrett’s 
esophagus with high grade dysplasia to locally advanced 
tumors after neoadjuvant therapy, which are also the 
indications of open esophagectomy[74]. Some aspects 
such as oncological outcomes, anastomosis location or 
patient positioning are, however, controversial. There 
are to date only a few works reporting long-term 
oncological outcomes and they have a short follow-up 
and a small number of patients, but they have failed, 
up to now, to show benefits by comparison with open 
esophagectomy[78,79]. Probably, because of this, and 
despite the MIE procedures increasing, today only 30% 
of esophagectomies are performed worldwide through 
minimally invasive approaches, with 20% in 2009 
in Japan or 19% in the United Kingdom in the last 8 
years[80-82].
Patient positioning influences the MIE technique. 
In the MIE as well as in the open technique, the left 
lateral decubitus has been more frequently used, 
although the prone decubitus is now been increasingly 
used. In 2012, the first controlled randomized 
trial analyzing this position was published[83]. Fifty-
nine MIE patients who were operated on in prone 
decubitus were compared with 56 patients treated 
by esophagectomy through a thoracotomy in semi 
lateral left decubitus. A significant decrease in 
respiratory complications in the MIE group was found 
by comparison with the open group (9% vs 29%). It is 
not clear whether the benefits are due to the position 
or the minimally invasive approach or, more probably, 
a combination of both. However, recent studies 
comparing both positions[84,85] show that the prone 
decubitus provides some advantages such as better 
oxygenation and exposition of the surgical field, which 
lead to improved postoperative outcomes. As a result, 
the prone decubitus is being increasingly used.
Regarding the anastomosis location, the Mc-
Keown technique with cervical anastomosis, using 
thoracoscopy only for the esophageal mobilization, has 
been the most used procedure to date since a lower 
skill is needed by comparison with the intrathoracic 
anastomosis. However, the McKeown technique 
is associated with high complication rates such as 
recurrent laryngeal nerve injury, and anastomosis 
leak. As a result, there is a tendency to perform more 
intrathoracic anastomoses. In 2012 a large series 
of 1000 MIE patients compared 481 cases treated 
by the McKeown technique with 530 with the Ivor 
Lewis procedure[86]. The outcomes in both groups 
were similar with low mortality rate and a similar 
number of retrieved lymph nodes, but the authors 
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concluded that Ivor Lewis MIE is preferable because 
a lower frequency of recurrent laryngeal nerve injury 
and a mortality rate of 0.9%, not higher than that of 
McKeown. Similar outcomes were found in another 
study from 2014 comparing 103 Ivor Lewis MIE with 
185 McKeown MIE[87], with significantly better results 
found in the first group: overall morbidity (16.5% vs 
31.4%), respiratory complications (8.7% vs 25.9%), 
anastomosis leak (1.9% vs 13%), anastomosis 
stenosis (0% vs 4.9%), and recurrent laryngeal nerve 
injury (1% vs 7.0%).
Nevertheless, intrathoracic anastomosis in difficult 
to do through a minimally invasive approach, so there 
is a limited number of papers reporting more than 50 
cases each in the last 2 years[88-92].
Robot-assisted esophagectomy
Some limitations of the MIE can be overcome by 
the aid of the robotic systems, which provide some 
advantages such as a tridimensional view of a field 
selected for the surgeon instead of the assistant-, the 
7 degrees of freedom allowing movements similar 
to open surgery, the tremor suppression resulting in 
a better precision, and a better ergonomics which 
leads to less surgeon fatigue. All of these advantages 
are even greater in small surgical fields, with few 
instrument exchanges as the thoracic phase of an 
esophagectomy is.
The first robot-assisted MIE using the Da Vinci 
system was published by Kernstine et al[93] in 2004. 
A few short series, between 6 and 47 cases, have 
been reported since then, always with cervical 
anastomosis[94-99]. The first robot-assisted Ivor Lewis 
series were published from 2013 to now, reporting 
22[100], 17[101], and 50[102] cases, respectively, all with 
the patient in lateral decubitus. In 2014 our group 
published the first series of robot-assisted Ivor 
Lewis in prone decubitus with intrathoracic manual 
anastomosis[103]. We feel that the prone position 
makes the dissection and lymphadenectomy easier, in 
an optimal field. We had no respiratory complication 
in 39 cases, although a stapled anastomosis, either 
transthoracic or transoral, is more difficult. The robotic 
assistance makes a manual intrathoracic anastomosis 
easier and allowed us to use the prone position and its 
potential advantages without flawing short and long-
term oncological outcomes, as we recently reported in 
a series of 21 cases[104].
Despite these potential advantages, the evidence 
to show any possible superiority of the robot-assisted 
MIE over either open esophagectomy or conventional 
thoracoscopic esophagectomy is still very limited. 
Since 2012 a single center controlled randomized trial 
has been ongoing in the Netherlands to compare the 
robot-assisted and open esophagectomy[105], with a 
recruitment prevision of 112 patients - 56 per arm and 
a follow-up of 5 years. However, for stronger evidence, 
multicentric trials with a large number of patients is 
needed.
MINIMALLY INVASIVE GASTRECTOMY
Gastric cancer incidence is decreasing but is still fourth 
in the world ranking and accounts for 10% of the overall 
cancer deaths. There are wide geographic variations, 
not only in incidence but in their clinical features also. 
Fifty percent of world cases are diagnosed in Asia and 
it is the most common cancer in South Korea[106]. In 
the western world there is a trend for tumors to be 
advanced at diagnosis, to locate more proximally, to be 
histologically diffuse, and the patients tend to be older - 
10 years more on average, to have an increased body 
mass index and more comorbidities[107]. Because of 
these differences, two classification systems have been 
developed - the Japanese Gastric Cancer Association 
(JGCA) and the Union for International Cancer Control 
(UICC/TNM)[108,109]. Also, different concepts concerning 
the optimal surgery, the reconstruction type and the 
minimally invasive surgery implementation have arisen 
between the West and the East. Fortunately, unification 
of the classification systems and approximation of the 
lymphadenectomy extent have been achieved in the 
last decade. As a result, the D2 lymphadenectomy 
has been implemented in the West[110,111] and in 
the East now is accepted that no more than a D2 
lymphadenectomy is mandatory[112].
The same as in other procedures, minimally 
invasive gastrectomy (MIG) in case of cancer could 
show some advantages. These techniques were pio-
neered by Kitano et al[113] in 1992 with a laparoscopic 
-assisted gastrectomy. Since then, the development 
has been determined, not only by the tumor features 
- location and stage, but also by the above mentioned 
differences between the West and the East. In general, 
the high incidence or early tumors in the East led to 
7341 distal and 1103 total laparoscopic gastrectomies 
in 2009 in Japan, and 3783 laparoscopic procedures 
in South Korea, in contrast with 245 in Spain between 
2005 and 2008 and 133 in the United Kingdom 
between 2011 and 2012[114].
Laparoscopic distal gastrectomy 
For tumors in early stage and distal location, literature 
is profuse in retrospective studies, case series and 
comparative studies but there are seldom randomized 
controlled trials (RCTs) comparing Laparoscopic 
distal gastrectomy (LDG) with open gastrectomy and 
they have a limited case number[115-122]. Despite the 
limitations, LDG appears to have advantages over open 
gastrectomy in terms of postoperative pain, recovery 
of gastrointestinal and pulmonary function, hospital 
stay and return to normal activity. The complexity 
of a proper lymphadenectomy - especially if a D2 is 
mandatory, and the concerns about oncological safety 
has slowed down its generalization[123]. 
Additional evidence has been provided by several 
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meta-analysis[124-127], some of them with more than 
3000 patients including advanced stages[128-131] and 
the most recent with 2144 cases[132]. All coincide in the 
LDG perioperative advantages - blood losses, overall 
morbidity, hospital stay - and that oncological results 
are not inferior to those of open surgery, although 
more operative time is spent. 
Currently two multicentric phase Ⅲ RCTs are 
ongoing, one from the Japan Clinical Oncology Group[133] 
and another from the Korean Laparoendoscopic 
Gastrointestinal Surgery[134]. The joined recruitment 
prevision is more than 2300 patients and the results are 
expected for 2015.
At the moment, and after the international expert 
group meeting, the LDG is accepted for distal tumors 
cT1-2 cN0 and the laparoscopic total gastrectomy (LTG) 
for proximal tumors cT1 cN0, although no consensus 
was achieved for other stages[135].
Literature data concerning LDG in locally advanced 
tumors (stage Ⅱ and Ⅲ) are even scantier. Only two 
RCTs have compared MIG and open gastrectomy[136,137]. 
Two meta-analysis, have been published: the first 
included 7 studies with 174 laparoscopic and 278 open 
gastrectomies[138], and the second analyzed 10 studies 
with 495 laparoscopic and 544 open gastrectomies, 
both with D2 lymphadenectomy[139]. Both coincide 
in that the minimally invasive approach in advanced 
gastric cancer is associated with a longer operative 
time, but less blood losses, pain, postoperative 
complications and hospital stay. Similar lymph node 
number and overall survival were found in the two 
approaches.
A recently published phase Ⅱ prospective clinical 
trial with 157 patients concluded that laparoscopic 
gastrectomy with D2 lymphadenectomy for advanced 
gastric cancer is technically feasible and safe, with 
acceptable morbidity and mortality rates[140]. 
More high quality RCTs comparing open and 
laparoscopic gastrectomy are needed, as well as 
multicentric studies. Even so, some aspects will 
probably not able to be applied to the West due to the 
above mentioned clinical and histological differences.
Laparoscopic total gastrectomy 
The Laparoscopic total gastrectomy (LTG) spreading 
has been slower worldwide, even in Korea and Japan, 
due to the need of an esophagogastric anastomosis, 
which is technically demanding, and because of the 
low incidence of the proximal gastric cancer in the 
East. The first relatively large series appeared in 2009, 
such as that of Shinohara et al[141] with 57 patients or 
the multicentric study from South Korea by Jeong et 
al[142] of 131 laparoscopic-assisted total gastrectomies. 
Both conclude that LTG is feasible and safe - morbidity 
of 31% and 19%, respectively with no mortality, it is 
possible to retrieve sufficient lymph nodes - 46 and 
35, respectively - although with long operative times - 
4.5 h on average.
In the West, the European pioneer groups in this 
field, such as Dulucq et al[143] or Huscher et al[144] 
published a series of only 8 and 11 LTG, respectively. 
In 2013, a specialized center, the MSKCC published a 
series of 17 cases[145]. 
Three recent meta-analysis[146-148] also suggest 
that, in skilled hands, LTG has better perioperative 
outcomes than the open procedure in terms of blood 
losses, pain, resumption of oral intake, hospital stay, 
with no inferiority concerning lymph node retrieved 
and survival. However, the operative times are longer.
A phase Ⅱ multicentric prospective trial (KLASS-03) 
in patients with stage Ⅰ gastric cancer is currently 
ongoing, with the aim of assessing perioperative 
morbidity and mortality of LTG by comparison with the 
open procedure[149].
Robot-assisted gastrectomy
The main advantages of the robotic systems have 
already been discussed. In the case of gastric cancer, 
these potential advantages lie in a better precision 
for the lymphadenectomy and an improved skill for 
intracorporeal anastomosis[150]. Hashizume et al[151] 
published the first Robot-assisted gastrectomy (RAG) in 
2002, but because the procedure is technically complex 
and the equipment is expensive, the spreading has 
been slow. Several groups have compared the RAG 
with the laparoscopic and open techniques. The 
Yonsei University group published in 2009 the initial 
experience with 100 patients, extended to 236 cases 
more (73% subtotal and 27% total) in 2011 of RAG 
compared with 591 laparoscopic (81% subtotal and 
19% total). They concluded that RAG seems to have 
better short-term results with comparable oncological 
outcomes[152,153]. Other published series until 2012 
support these conclusions, although the largest one 
reports less than 40 cases[154,155]. The first meta-
analysis, also from 2012, compared 268 RAG with 650 
laparoscopic gastrectomies[156]. Significant differences 
were not found in overall morbidity, hospital stay, or 
number of lymph nodes retrieved. 
Interesting, to make the most of the benefits 
of the robotic assistance, the morbidity due to ana-
stomotic leak must be minimal. A study analyzing 
postoperative complications in 5839 patients (4542 
open, 861 laparoscopic and 436 robotic gastrectomies) 
concluded that, even in expert hands, minimally 
invasive techniques are associated with an increased 
risk of anastomotic leak by comparison with open 
gastrectomy, although the overall morbidity and 
mortality rates were similar[157].
Since 2012, seven new meta-analysis have been 
published, analyzing between 404 and 762 RAG 
patients[158-164]. All concluded that RAG was associated 
with lower blood loss and shorter hospital stay, with 
an adequate lymphadenectomy, by comparison with 
the laparoscopic and open gastrectomy, although with 
longer operative times. 
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More high quality studies are needed to clearly 
define the role of RAG.
MINIMALLY INVASIVE BARIATRIC 
SURGERY
Obesity is a world health problem of epidemic 
dimension in western countries[165,166]. A WHO report 
estimates that more than 1600 million people are 
overweight and 400 million people have frank obe-
sity[167]. The increase in obesity prevalence is associa-
ted with a rise in the associated disease prevalence 
such as diabetes mellitus, hypertension, hyperlipi-
demia, obstructive sleep apnea, cardiovascular and 
pulmonary disorders, some tumors, osteoarticular 
disorders, and depression[167,168]. Life expectancy 
of obese patient is approximately reduced by 12 
years[167]. Bariatric surgery has been shown to be the 
most effective treatment to achieve significant and 
sustained weight loss[169-173] and also improves every 
cardiovascular risk factor, with the exception of the 
hypercholesterolemia[174]. These comorbidities lead to 
an increased consumption of health resources, and as 
a result, to increased costs of obesity treatment.
The therapy of this disorder includes both medical 
and surgical treatment. The former is based on a 
multidisciplinary approach with the participation of 
endocrinologists, dieticians and psychologists. The 
aim is to achieve a change in the life style, promoting 
physical exercise and healthy nutritional habits with 
the support of multiple drugs of limited efficacy[175,176]. 
The current surgical techniques can be divided into 
restrictive (adjustable gastric banding and sleeve 
gastrectomy), malabsorptive (biliopancreatic diversion) 
and mixed (gastric bypass)[177,178]. Since 1993, these 
techniques are being increasingly performed laparo-
scopically with preference over the open approach[179]. 
Laparoscopy in obesity surgery offers several advan-
tages: less pain, lower frequency of wound infection 
and incisional hernia, less postoperative complications, 
shorter hospital stay, faster recovery and better 
cosmetic results[180]. Several early studies on vertical 
banding gastroplasty[181], adjusted gastric banding[182], 
and Roux-en-Y gastric bypass[183-186], support some 
of these advantages, although the mortality rate did 
not decrease, probably because of the limited number 
of cases in each series. Later, several reviews[187,188], 
including the 2009 Cochrane study, compared 
laparoscopic and open surgery, but no statistically 
significant difference was found regarding mortality, 
morbidity, reoperations or weight loss. 
Two reviews of observational studies conclude 
that the frequency of incisional hernia and wound 
infection are lower in laparoscopic surgery, although 
lacking a direct comparison with open procedures. 
The systematic review by Reoch et al[180] analyzed 
6 randomized studies including 510 patients with a 
minimum follow-up of 12 mo. The risks of reoperation, 
wound infection, incisional hernia, anastomotic leak 
and cause of death were studied. They found that in 
the laparoscopically treated patients a 75% and 89% 
decrease of wound infection and incisional hernia risk, 
respectively. The risk of reoperation, anastomotic 
leak, and death cause were, nevertheless, similar in 
the laparoscopic and open surgery groups. Another 
review of 361 studies including 85048 patients[189] 
analyzed the 30 d mortality and found a 0.28% rate 
for biliopancreatic diversion and duodenal switch and 
1% for revisional surgery.
The restrictive procedures are associated with 
lower mortality rates than the mixed techniques, 
and the malabsorptive procedures have the highest 
mortality. In the meta-analysis by Buchwald et 
al[189] a higher mortality is found in open surgery by 
comparison with the laparoscopic procedures, with 
the exception of BPD/DS. Higher complication rate 
has, however, been reported in laparoscopic cases[190]. 
Flum et al[191] published a population-based study 
of Medicare beneficiaries and found a laparoscopic 
surgery mortality at 30 d, 90 d and 1 year of 2%, 2.8% 
and 4.6%, respectively as well as higher mortality for 
individuals older than 65 years.
Morino et al[192] studied the mortality risk factors of 
several bariatric procedures, such as gastric bypass, 
banding gastroplasty, adjusted gastric banding, 
biliopancreatic diversion, biliointestinal diversion and 
other procedures in a 13871 patient retrospective 
analysis. They concluded that the laparoscopic 
approach significantly reduces the mortality risk, and 
the surgical technique, the open approach, a prolonged 
operative time, associated comorbidities and the 
surgeon experience increased the risk.
Mortality associated to laparoscopic bariatric 
procedures has been shown to be lower in centres with 
more than 100 cases per year (0.3%) than in those 
with less than 100 (1.2%)[193]. 
In summary, the laparoscopic approach significantly 
reduces the overall mortality risk, since the hazard 
of thromboembolism as well as other complications 
decreases by comparison with open surgery. However 
the evidence level of long term outcomes of most 
review studies are low since many patients are lost to 
follow-up in many series.
Robot-assisted bariatric surgery 
Robot-assisted bariatric surgery (RABS) has been 
used since 1998, when a gastric band was put 
from the distance[194], and shows some advantages 
over the laparoscopic techniques, which have some 
limitations related with a poor ergonomics due to 
a limited instrument mobility due to the abdominal 
wall width, and hepatomegaly. RABS suppresses the 
position port limitation as well as the physiological 
tremor and confers a better ergonomics[195]. The three 
dimensional view allows a more precise dissection[196] 
and a decrease in blood loss. A shorter learning curve 
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by comparison with conventional laparoscopy has been 
claimed[197]. 
Several studies report that RABS is safe with 
lower complications than the laparoscopic techniques. 
Edelson et al[198] compared 287 robotic and 120 
laparoscopic gastric banding cases, and they did not 
find any significant difference in intraoperative or 
postoperative complications, hospital stay or operative 
time; the time was, however, significantly lower in 
patients with a BMI > 50 kg/m2 operated on through 
a robotic approach (91 min vs 103 min).  Fourman et 
al[199] reported similar findings in a literature review of 
RABS which included gastric banding.
The gastric bypass has been used since 2000, 
with satisfactory outcomes[200]. Lower complication 
rates than those of the laparoscopic approach, 
without mortality or anastomotic leaks have been 
published[199,201-205]. Others also report significantly 
less anastomotic failures with RABS[206]. Skilled teams 
have achieved similar operative times and even 
shorter[199,206,207], with comparable long-term results 
concerning weight loss and comorbidity improvement.
In a review of 1686 patients comparing laparo-
scopic and robotic bypass, similar results were 
found regarding anastomotic leaks, postoperative 
complications, operative time and hospital stay[208]. 
However, an advantage was found in a decrease of 
the anastomosis stenosis rate at 6 mo. Most groups 
coincide in that anastomosis leak is lower with RABS, 
although without reaching statistical significance.
The vertical gastrectomy or sleeve gastrectomy 
(SG) has become in one of the most popular bariatric 
procedures due to its effectiveness in reducing weight. 
Overweight losses as high as 61% after 24 mo have 
been reported[209], as well as comorbidity improvement 
such as diabetes resolution in 47%-66%[210,211]. Other 
advantage are the lower operative time needed, 
the shorter hospital stay and the lower frequency of 
complications, by comparison with the laparoscopic 
GB. Since the use of robotic surgery has been limited 
to the most complex procedures - revisional surgery 
and gastric bypass, there are only a few studies 
on SG[199,211-217] which do not show any significant 
difference concerning complication frequency - stenosis, 
bleeding-, mortality or hospital stay. One study reports 
a lower fistula frequency and a shorter stay in the 
robotic cases, but without statistical significance[218]. 
This technique, when performed with robot assistance, 
is associated with longer operative times and is more 
expensive, and thus is controversial its generalized use. 
However, it is proposed as a way to learn robotic skills 
before performing the gastric bypass.
The Scopinaro biliopancreatic diversion (BPD) and 
the biliopancreatic bypass with duodenal switch (DS) 
are more effective than the gastric bypass in achieving 
weight loss and improvement of obesity associated 
comorbidities[219,220] but due to their complexity, higher 
complication rates and the need of nutritional control, 
are the least used. The first results of these procedures 
performed through a laparoscopic approach were 
published by Ren et al[221] in 2000, with a 2.5% 
mortality. In a systematic review, a 30-d mortality 
of 0.1% for restrictive procedures, 0.5% for gastric 
bypass and 1.1% for BPB/DS were reported 59. Sudan 
et al[222] reported a series of 59 robotic BPB/DS without 
mortality, anastomotic leaks, bleeding, sepsis or 
pulmonary thromboembolism. 
The main criticism to RABS is its high cost, as well 
as the longer operative time, especially because of the 
preoperative docking time needed. This however, can 
be minimized with increasing experience of the surgical 
team.
LIVER SURGERY
Nowadays, laparoscopic resection is increasingly being 
performed for both benign and malignant liver lesions. 
This review will focus on the latter.
There are several options to perform a laparoscopic 
liver resection (LLR): totally laparoscopic, hand-
assisted and hybrid resection. In the latter, the liver 
is mobilized laparoscopically, with the hilar dissection 
and parenchymal division performed through an 
abdominal incision, usually epigastric as described by 
Koffron et al[223]. Hand-assisted laparoscopy and the 
hybrid technique have been recommended as a bridge 
to the totally laparoscopic technique as the first steps 
of surgeons not familiar with complex laparoscopic 
procedures[224]. There is not sufficient data supporting 
the superiority of any technique over the other in 
terms of operative time, blood losses or complication 
rates[225]. 
Every type or liver resection has been performed: 
from non-anatomic resection to segmentectomy or 
right lobectomy, removing from one tumor node 
to multiple nodes[226]. Pedicle control can be done, 
the same as in open surgery, in order to minimize 
bleeding.
Laparoscopic liver surgery is associated with 
some potential benefits by comparison with the open 
technique. There is a better view due to magnification 
and favorable vision angles. This is the case of the 
adrenal glands and the area around the inferior vena 
cava, since these structures are located on the dorsal side 
of the liver and are best seen by a laparoscope inserted 
through the umbilicus[227]. There is also less bleeding 
with less transfusion needs, as most papers show[226], 
explained in part by the laparoscopic magnification, and 
decreased venous oozing from the cut surface under 
pneumoperitoneum[227]. Another explanation is a longer 
portal clamping time by comparison with open surgery, 
as reported in some works[228], although this is not seen 
in others[226]. The lower analgesia requirements are 
due to less postoperative pain[228]. A lower frequency of 
postoperative complications has been claimed; several 
papers have reported a trend to decreased complications 
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rates, although without significant differences[229-232]. 
Particularly, a lower overall incidence of pulmonary 
complications has been reported[233]. A recent published 
metaanalysis reports a significant decrease in the 
complication rate of laparoscopic cases[226], but other 
studies find similar complications in laparoscopic and 
open groups[228]. Other advantages are shorter in - 
hospital stays - due to less pain and less complications-, 
better cosmetic results. Lower frequency of incisional 
hernia. Further resections, if necessary, or even salvage 
transplantation in the case of hepatocellular carcinoma 
(HCC) are probably easier and this could increase the 
re-resection rates. All of this without compromising 
the oncologic aims as free borders (R0 resection)[228]. 
Increased liver regeneration has been reported in living 
donor patients operated by laparoscopy by comparison 
with open procedures[234]. Although the reason is unclear 
and these findings have to be confirmed, the diminished 
acute-phase stress response and improved immune 
system function reported after laparoscopic surgery 
could explain this in part.
There are however some concerns regarding 
the laparoscopic technique. The first is the problem 
of venous gas embolism[230]. Since the pneumo-
peritoneum rises intrabdominal pressure, an increased 
risk of CO2 embolism is possible, although because 
of its greater solubility than nitrogen, it is much 
safer. Also, the use of argon beam coagulation could 
increase the risk of argon gas embolism. As a result, 
some authors recommend its avoidance or extremely 
cautious use[224], only over minor bleeding points 
and opening one port to allow venting excessive 
gas pressure. Concerns also remain regarding the 
oncologic adequacy of LLR compared with open liver 
resection as well as failure to detect occult lesions, 
which is especially important in the case of metastases. 
This will be discussed later. There is a potential risk 
of tumor dissemination (port metastasis, peritoneal 
carcinomatosis). In case of major bleeding, the 
restriction on movements make the suture difficult[227], 
leading to important risks. On the other hand, 
laparoscopic procedures might result in additional 
hospital costs due to the need for laparoscopic 
instrumentation, and possibly longer operative times. 
However, these costs can be offset by shorter lengths 
of stay. Estimates of costs in some centers find that 
the laparoscopic approach is not associated with higher 
costs[230]. 
The advent of minimally invasive liver surgery could 
result in overuse of these procedures. Some authors 
have stated with caution that laparoscopic procedures 
could lead to their use in cases where surgery is not 
indicated and therefore that laparoscopic procedures 
should only be used when an open procedure is clearly 
indicated. However, some authors argue that in some 
cases, especially when faced with diagnostic and 
therapeutic dilemmas, laparoscopic procedures might 
be considered instead of conservative nonsurgical 
management[231]. 
Most published papers report case series of 
laparoscopic resections, usually comprising a small 
number of patients. To date there are no published 
randomized clinical trials. In addition, few works have 
reported comparisons with open resection. This is 
probably due to the difficulty of putting together a 
team skilled in both advanced laparoscopic and open 
hepatic surgery.
Conversion rates are variable. The reasons are 
oncological, bleeding, strong adhesions due to previous 
surgery and no progression for anatomical reasons.
Transection methods are variable but any energy 
device or staplers can be used. For deeper transection, 
an ultrasonic aspirator (CUSA or equivalent) or the 
clamp-crushing technique can be used[224].
Indications for LLR are the same as those of open 
surgery: large and symptomatic benign lesions, 
diagnostic concerns and, especially malignant tumors. 
The latter comprise any type of malignancy, but 
most frequently, colo-rectal metastases, HCC and 
cholangiocarcinoma. Our discussion will be focused on 
the malignant lesions.
Recently, the Second International Consensus 
Conference published their recommendations for LLR. 
They found these were not inferior to open resection 
in mortality, postoperative complications, margin 
negativity, overall survival, and costs. Laparoscopy 
was superior in length of stay. Also, technical 
recommendations were provided. They state that 
minor LLR (less than 3 segments) is “confirmed to 
be a standard practice in surgery but is still in an 
assessment phase”. They also state that “major LLR is 
an innovative procedure and is still in an exploration or 
learning phase and has incompletely defined risks”[224].
LIVER METASTASES
When several years ago laparoscopic LLR began, 
some concerns regarding liver metastasis resections 
arose: will free margins can be achieved? Will small 
metastases be found[235]? No trials comparing open 
and laparoscopic metastasis resection were available 
in 2009 when the few available studies reported an 
80%-87% 3-year overall survival[235]. Nowadays we 
have some studies which allow comparing several 
aspects of open and laparoscopic surgery.
As mentioned above for liver resections in general, 
most published papers concerning metastasis reports 
a negligible or nihil mortality with a trend to a lower 
complication rate in laparoscopic series[226,232], although 
this is not seen in other works[229,236]. Also, the bleeding 
and transfusion needs are significantly lower than in 
open surgery[226,229,237-239].
The mean operation time ranges from 180 to 377 
min - depending on the resection extent - which is 
similar to the time spent in open resections[226,229,237-239].
The length of stay ranges from 3.7 to 7.3 d[226,229,237-239] 
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and 18.3 in a study from Japan[230] but is significantly 
shorter in laparoscopic resections in all of them.
Concerning oncologic outcomes, the papers report 
R0 resection rates ranging 82.7%-100%, not different 
from those obtained in open resections[226,229,232]. 
The long-term outcomes - overall and disease-free 
survival - are also similar. The 5-year overall survival 
rate found in the metaanalysis by Schiffman et al[226] 
is 51.4%, although rates as high as 76% have been 
reported[226]. In addition, non-significant differences 
have been found when compared with survival 
after open procedures[226,229,232,237]. Importantly, no 
significant difference between laparoscopic and open 
resections disease-free survival has been found[226,237], 
reflecting that no missed metastasis was left behind 
after laparoscopic procedures. 
HCC
Resection is the usual therapy for HCC in non-cirrhotic 
patients. However, most cases in the western world 
arise in cirrhotic patients. This implies to deal with 
a liver with some functional impairment as well as 
more fibrotic tissues. Current guidelines recommend 
resection only in solitary tumors when portal hyper-
tension has been excluded and serum bilirubin is 
normal[240]. Although the best candidates are those 
patients with tumors up to 5 cm of diameter, resection 
in bigger tumors is also acceptable[240]. Anatomic 
resections are recommended because of its better 
survival rate than wedge resections[230,240]. 
In 2007 some benefits - reduced blood losses 
and morbidity in cirrhotic patients as compared with 
open resections, especially with lower frequency of 
postoperative ascites - were already recognized for 
the laparoscopic approach[241]. The possible benefits 
of laparoscopy in cirrhotic patients can be due to 
preservation of the abdominal wall and round ligament, 
which avoids interruption of collateral circulation 
and, therefore, preventing a rise in portal pressure; 
less mobilization and manipulation of the liver which 
reduces liver trauma; avoidance of exposure of the 
abdominal viscera, which allows to restrict fluid 
requirements and decreases electrolytic and protein 
losses; and by reduction of intraoperative blood losses.
A recent metaanalysis of studies dealing with 
HCC in both cirrhotic and non-cirrhotic patients found 
lower rates of bleeding and transfusion requirements 
in laparoscopic resections, by comparison with open 
procedures[242]. There were no significant differences in 
operation time. Concerning complications, lower rates 
of postoperative ascites and liver insufficiency were 
found. However, the frequency of other complications 
such as bile leakage, postoperative bleeding, intra-
abdominal abscess, and mortality was similar[242,243]. 
These results ought to be interpreted cautiously since 
not all the analyzed patients were cirrhotic. The length 
of hospital stay appeared to be similar after both 
approaches[242].
Concerning oncologic results, significant differences 
in free margin rates have not been found[242], although 
in a non-randomized study it was significantly higher 
in LLR than in open surgery[244]. Both overall and 
disease-free survival have been shown to be similar in 
cirrhotic patients[242-244]. Also, tumor recurrence seemed 
similar[242-244].
As a result, LLR for hepatocellular carcinoma 
appears feasible and safe both in cirrhotic and non-
cirrhotic patients, provided the functional status of the 
latter is acceptable. Also, oncologic long-term results 
are not inferior to those of open surgery.
CHOLANGIOCARCINOMA 
Laparoscopy can be used in cholangiocarcinoma both 
for staging work-up and for therapy.
Cholangiocarcinoma (CC) has considerable rates of 
unresectability due to the common invasion of vessels, 
secondary and tertiary biliary duct divisions, presence 
of distant lymph node metastases and peritoneal 
metastases. Staging laparoscopy (SL), often combined 
with ultrasound, detects many of this settings, 
therefore avoiding unnecessary laparotomies and has 
been used with staging purposes for many years. The 
usefulness appears to have decreased considering 
reports from 2002 and from 2011, showing a drop 
both in efficacy (41.8% to 14%) and accuracy (72% 
to 32%)[245]. This decrease can be explained by the 
continuous improvement in imaging techniques which 
detect today minimal disease. As a result, today the 
most extended opinion is that SL only is indicated in 
case of concerns of unresectable disease on imaging 
techniques or in patients with high risk of holding it, as 
T2/T3 cases of the Jarnagin-Blumgart staging system 
are[246].
On the other hand, experience with laparoscopic 
treatment of CC is short, with most papers reporting 
only a few cases of laparoscopic[247,248] or robot-assisted 
laparoscopic treatment[249]. Two case series report 14 
cases each. Yu et al[250] treated 8 Bismuth Ⅰ tumors 
by local excision and 6 Bismuth Ⅱ cases by partial 
hepatectomy. The R0 resection rate was 100% in the 
former but only 60% in the latter. Importantly, they do 
not perform caudate lobe excision. Overall, there was 
no mortality and there was 35.7% of biliary fistula. 
They report two tumor recurrences. Gumbs et al[251] 
report a multicenter experience of 9 intrahepatic and 
5 perihilar CC. The former were treated by partial 
hepatectomy as well as 3 of the perihilar tumors, with 
a conversion rates of 11% and 20%, respectively. 
No caudate lobe resection was carried out. The R0 
resection rate was 77.7% in the intrahepatic and 80% 
in the perihilar CC. In the intrahepatic CC the mortality 
and morbidity rates were 11% and 33%, respectively, 
whereas in the perihilar CC there was no mortality or 
complications. The survival rates were 66.6% at 22 mo 
in the intrahepatic and 100% at 10 mo in the perihilar 
CC.
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Concerning robot-assisted surgery, there is an 
anecdotal published case of hilar CC treated by 
extended right hepatectomy and bile duct excision[249]. 
They had free margins with no complications.
This scanty experience allow us to conclude that 
laparoscopic treatment of CC is feasible and that 
the rates of mortality, morbidity and survival are 
comparable to the open surgical procedures.
In the absence or randomized control trials is difficult 
to reach any conclusion concerning superiority of 
laparoscopic over open resection. For the moment, only 
clinical data mainly coming from case series performed 
in highly specialized centers show comparable oncolo-
gical results and some advantages in hospital stay. 
LIVING-DONOR LIVER TRANSPLANT
Right lobe living donor liver transplantation is the 
usual way of adult-to-adult live liver transplantation. 
Laparoscopic approach for liver procurement has 
been used in a few reports. The procedure has 
been performed as totally laparoscopic right or left 
hepatectomy[252-257] and laparoscopically assisted using 
a hand port system[256,257]. Also, the hybrid technique 
has been performed[256] because some authors claim 
a shortening in the prolonged operative times of the 
procedure with this technique[256]. The reported donor 
outcomes were satisfactory with low complication rates 
-most of them minor- and without mortality[252-257].
Some studies have compared the laparoscopic 
and open techniques. Baker et al[234] studied donor 
right hepatectomies and found in the donor similar 
rates of complications, estimated blood losses, and 
hospital stays, as well as shorter operative times and 
higher liver regeneration volumes in the laparoscopic 
group. Kim et al[258] studied left lateral sectionectomies 
and found a significantly shorter hospital stay and 
time to oral diet in the laparoscopic group. Duration 
of operation, blood loss, warm ischemia time and 
complications were comparable, with no deaths in any 
group.
In summary, every liver resection procedure 
seems safely feasible through a laparoscopic approach 
provided the surgeon has proper training in both 
complex laparoscopic and liver procedures. The 
learning curve for this training has been estimated in 60 
cases[259]. Short and long-term results for metastases 
and hepatocellular carcinoma are as good as in open 
procedures, with shorter in-hospital stay and a trend 
for less complications and intraoperative bleeding. The 
Second International Consensus Conference considers 
that there are insufficient evidence from few centers to 
give any recommendation[224].
ROBOTIC HEPATECTOMY
Theoretical advantages of robotic over laparoscopic 
hepatectomy are increased freedom degrees of the 
instrument movements, abolition of the physiologic 
hand tremor and 3-dimensional view. Also easier 
suture ligation for vessel control rather than stapling 
has been claimed as well as easier retrohepatic 
dissection thus facilitating access to the hepatic 
veins[260,261]. Intracorporeal suturing and tying in 
difficult locations can also be facilitated by the robotic 
technology. 
Among the disadvantages of robotic hepatectomy 
are the longer times required to dock the robot, to 
exchange instruments, and to reposition or redock the 
instruments if the viewing field has to be changed. 
Also, the lack of tactile sensation when suturing and 
knot tying might lead to injury due to uncontrolled 
tissue overstretching or suture disruption[262].
Although the published experience on robotic 
hepatectomy is scanty, Ho et al[262] published a 
systematic review in 2013 comprising data of more 
than 200 patients. The procedures performed 
included wedge resection, segmentectomy, right and 
left hepatectomy and left lateral segmentectomy 
for both benign and malignant diseases. A right live 
donor hepatectomy was also done. The conversion 
rate was 4.6%. Mean operation time was variable, 
ranging 200 to 507 min. The morbidity rate was 
20.3%, with bile collections and abdominal abscess 
being the most frequent complications. No mortality 
has been reported. It can be concluded that robotic 
liver resection is safe and feasible when performed by 
experienced surgeons.
Because of the relatively short follow-up, results 
concerning cancer-specific survival are scanty and 
most papers only report some recurrence cases. As a 
result it is too early to draw any conclusion concerning 
oncological results.
Some studies comparing robotic vs laparoscopic 
hepatectomy in both benign and malignant lesions 
have been published. 
Ji et al[261] showed that robotic hepatectomy is 
safe and feasible, with slightly lower complication and 
conversion rates than traditional laparoscopic and 
open resections. However, longer operative times 
and hospital stays were found by comparison with 
laparoscopic procedures, as well as increased costs. On 
the other hand, Berber et al[263] did not find significant 
differences in operative time in a comparison between 
a small series of robotic and laparoscopic resections.
Tsung et al[260] recently reported 51 robotic resec-
tions. Importantly, liver mobilization and adhesiolysis 
were carried out by conventional laparoscopy prior 
to robotic docking for transection. When compared 
with matched laparoscopic resections, no significant 
differences in blood losses, postoperative complication 
rates, mortality rates, postoperative intensive care unit 
admission rate, length of stay or margin involvement 
were found. Robotic resections used up more operation 
room time, although leading to less conversions than 
laparoscopic resections did.
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In summary, although robotic liver resection 
is feasible in skilled hands, experience is very 
short. Indeed, the Second International Consensus 
Conference considers that there is insufficient data for 
evaluation[224].
PANCREATIC SURGERY
Different types of laparoscopic pancreatic resection are 
performed: tumor enucleation, distal pancreatectomy, 
central pancreatectomy, pancreatico-duodenectomy 
and total pancreatectomy, although the latter is 
anecdotal. These techniques have been used for 
both benign (chronic pancreatitis, cystic tumors) and 
malignant diseases. 
Tumor enucleation
Although in general formal pancreatic resection is 
recommended for most tumors, enucleation can be 
performed for neuroendocrine neoplasms if tumor 
size does not exceed 2 cm and if no findings of 
malignancy are detected on preoperative staging[264]. 
Pancreatic tumor enucleation can be easily performed 
by laparoscopy with excellent morbidity and mortality 
outcomes[265].
Distal pancreatectomy (pancreatic left resection)
This is the most frequently performed type of 
laparoscopic pancreatectomy for both benign and 
malignant diseases[266,267]. 
Distal pancreatectomy can be accomplished with 
or without splenic preservation. Splenectomy could 
adversely influence oncologic long-term outcomes, in 
addition to predispose to infectious complications. As 
a result, efforts to preserve the spleen should be done 
in case of benign or low grade malignancies, provided 
that splenic vessels are not involved with the tumor. 
More controversial is splenic preservation in case of 
adenocarcinoma. Whatever the case, if the spleen is 
to be preserved, two techniques are used[264,268]: in the 
first, section of the splenic vessels both at the level of 
transection of the pancreas and at the splenic hilum 
is performed, leaving the short gastric vessels as the 
only blood flow supply. In the second technique, the 
splenic vessels are preserved by meticulous ligation 
of all the branches reaching the pancreas. However, 
patency of splenic vein - although not that of the 
artery - can be compromised after a laparoscopic DP in 
as high as 35%[269]. The frequency of splenic infarction 
and appearance of gastric varices is higher in case of 
splenic vessel section[268].
Blood losses have been reported to be significantly 
lower in case of a laparoscopic approach by comparison 
with open procedures[270-273]. Localizing small tumors 
by laparoscopy or laparoscopic ultrasonography can 
be difficult and this leads to conversion in many cases. 
Other causes of conversion can be bleeding or difficult 
structure identification which lead to conversion in 
17%-30% of cases[270-272]. Obesity is significantly 
associated to conversion[271].
The complication rate has been reported significantly 
lower in laparoscopic cases[271,274], although the severity 
grade was similar than in open procedures[263]. Other 
papers showed similar rates[272,273]. Tran Cao et al[267] 
studied a nationwide database and compared the 
short-term outcomes of 382 minimally invasive distal 
pancreatectomy (mainly laparoscopic and some 
robotic) with those of open distal pancreatectomy. They 
found a significant reduction in overall perioperative 
morbidity among patients undergoing minimally 
invasive surgery, including a significant decrease in 
hemorrhagic complications and postoperative infections 
in laparoscopically treated patients. Results of five 
meta-analyses[266] support these findings concerning 
overall perioperative morbidity, although clinically 
relevant pancreatic fistula frequency was significantly 
lower in laparoscopic cases only in one of the analyzed 
studies.
Patients converted from laparoscopic to open 
surgery have significantly more severe complications 
than those with not converted[271] which reflects the 
need of proper selection for a laparoscopic approach. 
The reported mortality ranges 0%-1%[267,271,273].
Some have reported operation times significantly 
longer in laparoscopic than in open procedures[271], but 
others find similar duration[273].
The hospital stay has also been reported to be 
significantly lower with a laparoscopic approach[27,270,271,273]. 
A recently published meta-analyses[275], comprising 
data of 3701 patients, all of them from non-randomized 
studies, confirmed most of the above mentioned 
findings: superiority of laparoscopic over open DP 
in terms of blood loss, time to first oral intake, and 
hospital stay. Mean operation time, mortality -0.4% 
in DP-morbidity and safety showed no difference. 
However, data concerning oncologic radicality and 
effectiveness are limited.
Distal pancreatectomy for adenocarcinoma
Most articles report a mixture of benign and malignant 
diseases as indication of distal pancreatectomy 
(DP). As a result, to reach conclusions concerning 
safety and oncological outcomes when dealing with 
adenocarcinomas is difficult. A few papers compare 
open and laparoscopic approaches only in case of 
pancreatic adenocarcinoma. Kooby et al[270] performed 
a multicenter matched analysis of 23 laparoscopic 
procedures compared with 189 open procedures and 
found no significant differences in positive margin 
rates, number of nodes examined or overall survival. 
The median follow-up was only 10 mo and, thus, it 
is premature to conclude that the long-term results 
are as safe as in open procedures. Magge et al[272] 
compared 28 patients with 34 operated on by an open 
approach. They found not significant differences in 
margin-negative resection (open, 88%; laparoscopic, 
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86%) and median lymph node clearance. Also, no 
significant differences were found for overall survival 
or risk of local recurrence.
Distal pancreatectomy for neuroendocrine tumors:
A recent paper compared laparoscopic an open 
DP performed for neuroendocrine tumors[274]. The 
laparoscopic procedure showed no mortality, a 
significant lower complication rate and shorter hospital 
stay. No significant difference was found concerning 
margin involvement, long-term survival, and overall 
costs.
In summary, DP is feasible, safe and reproducible 
for most laparoscopy skilled surgeons. Concerning 
its use in case of adenocarcinoma, it also appears as 
safe as open DP but more studies analyzing long-term 
results are needed.
Robotic distal pancreatectomy
Theoretical advantages and disadvantages of robotic 
surgery have been discussed earlier. The published 
papers dealing with robotic DP are still scanty.
Zureikat et al[276] report 83 robotic DP with no 
mortality and a low rate of severe complications, 
although with 43% cases of pancreatic fistula. The 
average operative time was 256 min and 2% required 
conversion.
Waters et al[277] compared 17 robotic against 
32 open and 28 laparoscopic DP. Cystic tumors 
predominated among the indications of robotic 
resection. In this group, longer operative times, 
similar blood losses, no mortality, shorter hospital 
stay and lower hospital costs were found. Higher rates 
of splenic preservation were achieved in comparison 
with the open and laparoscopic approaches. Daouadi 
et al[278] compared 30 robotic DP and 94 laparoscopic 
DP patients. The robotic DP group included more 
adenocarcinomas. Significant differences in blood loss, 
hospital stay, or morbidity were not found. However, 
there was a statistically significant 36% increase in R0 
resection with robotic surgery, as well as more lymph 
nodes harvested. Also the conversion rate was lower.
The study by Kang et al[279] included 20 robotic 
and 25 laparoscopic DP for benign and borderline 
malignant lesions. Although the intent was to preserve 
the spleen, the overall rate of splenic preservation 
was very low. A higher splenic preservation rate was 
achieved with the robotic approach. This took longer 
operative times and had increased costs compared to 
laparoscopic cases.
In summary, although feasible and safe, robotic DP 
has not yet shown clear advantages over laparoscopic 
DP.
Central pancreatectomy
This technique can be applied for the treatment of 
benign or borderline lesions of the pancreas situated in 
the pancreas neck. Although uncommonly performed, 
this technique is feasible by laparoscopy[265-280].
A review from 2013[281] collected 51 published 
cases operated on through total laparoscopy or robotic 
assistance. Pancreatic reconstruction was done with 
a Roux-en-Y pancreato-jejunostomy, or pancreato-
gastrostomy. The procedure was long with a mean 
time of 356 min. Blood loss was minimal in most 
cases. Mortality was nil, but morbidity was high, 
mainly due to pancreatic fistula (46%). 
When performed by a robotic approach, the 
procedure is associated with long operative times 
(mean: 394 min) and a 23% of severe complications, 
although without mortality[276].
Pancreaticoduodenectomy
Three techniques are currently employed for LPD: pure 
laparoscopy (PL), hand-assisted (HA) laparoscopy, 
and laparoscopic-assisted (LA) surgery. In contrast 
with DP, where only resection is to be performed, the 
pancreaticoduodenectomy (PD) requires a complex 
resection as well as pancreatico-jejunal, hepato-
jejunal and gastro-jejunal anastomoses. As a result, 
although feasible, the difficulty of the procedure 
makes that experience with laparoscopic pancreati-
coduodenectomy is limited to a few case series. 
Gumbs et al[282] analyzed most reported cases until 
2011 comprising 285 patients, although only 32% 
had pancreatic adenocarcinoma. The most important 
findings for the entire cohort were a 9% conversion 
rate, 2% mortality, 48% morbidity and a length of stay 
of 12 d. Margin involvement was found in 0.4% with 
an average of retrieved lymph nodes of 15. The mean 
disadvantage was a long operation time ranging from 
263 to 750 min.
Direct comparison between laparoscopic and open 
PD has been performed by some groups. The first[273], 
which included 60% of patients with malignant tumors 
- pancreatic, biliary, ampullary - found significantly 
lower blood losses, and hospital stay as well as more 
lymph node harvested in the laparoscopic group. 
However, the average operative time was significantly 
increased. There were no differences in overall 
complications, pancreatic fistula, delayed gastric 
emptying, and resection margin involvement. The 
main finding of the second study[283] was a significant 
reduction in blood losses and, thus, the transfusion 
need in the laparoscopic patients although it did not 
show relevant differences in morbidity.
Asbun and Stauffer[284] compared 53 laparoscopic 
and 215 open PD. They found significant differences 
favoring laparoscopic PD blood losses, transfusions, 
length of hospital stay, length of ICU stay (P < 0.001), 
and number of lymph nodes retrieved although the 
operative time was significantly longer. The rates of 
overall complications, pancreas fistula, delayed gastric 
emptying, margin involvement were not significantly 
different.
Kuroki et al[283] compared 20 laparoscopic and 31 
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open PD. They also report a significant reduction of 
blood losses and transfusion need but they did not find 
significant differences in morbidity.
Song et al[285] report a comparison between 137 
laparoscopic and 2055 open pylorus-preserving PD 
for periampullary tumors. A shorter hospital stay 
and a lower analgesic consumption was seen in the 
laparoscopic cases. No other difference was found 
including complications, blood losses margin involve-
ment or lymph nodes retrieved.
In a recent systematic review of several series[286], 
the operative time averaged 464.3 min (338-710 
min) with conversion in 9.1% of patients. The mean 
estimated blood loss was 575 mL. Average mortality 
was 1.9% and morbidity ranged between 18.1% and 
64.2%, with pancreatic fistula ranging between 4.5% 
and 52.3% of patients. An average of 14.4 lymph 
nodes were retrieved and 4.4% of cases had marginal 
involvement. 
In summary, laparoscopic PD is feasible and as 
safe as the open procedure in highly skilled hands 
and high-volume centers. Long operative times are 
needed. Decreased blood losses seem to be the 
main advantage. Concerning its use in case of adeno-
carcinoma, more studies are needed.
Robotic PD
Published experiences concerning robotic PD are even 
less common. Zureikat et al[276] report 132 cases with 
a 90 d mortality rate of 3.8% and a frequency of 
severe complications (Ⅲ-Ⅳ) of 21%. The frequency 
of pancreatic fistula was 17%, although only 3.7% 
were of grade C. Conversion was needed in 8%. The 
procedure took long operative times (mean 527 min), 
and although decreased with improved experience, the 
last cases of the series lasted over 400 min.
In the systematic review by Boggi et al[286], the 
robotic PD used up more operative time and had 
higher pancreatic fistula rate by comparison with pure 
laparoscopic PD (but not laparoscopically assisted 
PD). However, significant differences were not found 
concerning overall morbidity or mortality (2.7%, 1.1%, 
and 2.4% for pure laparoscopic, laparoscopically 
assisted, and robotic PD, respectively).
Another systematic review analyzed several non-
randomized studies comparing open and robotic 
pancreatectomies, most of them PD[287]. It included 
137 cases of robotic PD and 203 open PD. The median 
conversion rate was 10%. Overall complications, 
reoperation rate, and margin involvement were 
significantly lower in robotic group, with no significant 
difference in postoperative pancreatic fistula, and 
mortality. In one study included in this review[288] 
involving only PD, a significant increase in the R0 
resection rate, with 100 % of patients in the robotic 
group compared with 87% in the open group.
A recently published paper[289] comparing robotic 
and open PD, report similar findings such as lower 
blood losses, shorter hospital stay, longer operative 
times with no significant difference in morbidity, 
mortality, as well as R0 resection rate and number of 
lymph nodes retrieved in case of malignancy. Patients 
with pancreatic adenocarcinoma of both groups had 
similar overall and disease-free survival.
In summary, the same as laparoscopic PD, robotic 
PD is feasible in highly skilled hands and high-volume 
centers. Although the very short published experience 
makes to reach firm conclusions difficult, it suggests 
that robotic PD is as safe as laparoscopic PD with some 
advantages over open PD. However, the former is 
more time-consuming.
TRAINING IN LAPAROSCOPIC SURGERY
In 1889 Halsted established at the Johns Hopkins 
Hospital the need of a new training system in surgery. 
Nowadays, it is rewarding to see how surgeons can be 
proficient in several techniques when they repeat them 
in a simulator[290]. 
Today, traditional methods are not enough to teach 
and learn surgical skills because of the reductions in 
training hours during the residency programs and the 
lack of time of the surgeons to adequately teach these 
techniques. On the other hand, laparoscopic surgery 
learning curve and the risk of severe complications 
when inexperienced surgeons perform these pro-
cedures, make it more difficult for residents to learn 
minimally invasive techniques. 
Costs per procedure have increased with minimally 
invasive procedures and technology is making the 
surgical environment more complex. A surgeon 
does not learn alone anymore, and they depend on 
a complex team that has to be trained and work 
together. As a result, surgical training models are 
evolving to serve as a complement to the standard 
surgical training in the theatre[291]. 
Current situation of surgical residents training
With the arrival of laparoscopic surgery to the 
surgical departments in the 90s, the surgical resident 
training has suffered a huge transformation with a 
decrease in its autonomy. This has resulted in the 
need of additional training to obtain the confidence 
and maturity of judgment. As a result, the number 
of fellowships has dramatically increased during the 
last ten years. This change has enlarged the surgical 
training[290].
Laparoscopic surgery training programs have 
evolved in several ways in the different countries. 
Sweden or The Netherlands have national programs 
limited to basic procedures (cholecystectomy) using 
training techniques as virtual reality[292]. In the United 
States and Canada, the surgical training method is 
structured and the program of the American College 
of Surgeons (ACS) demands the inclusion of basic 
training in the Fundamentals of Laparoscopic Surgery 
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(FLS) in the residency programs[293]. Spain has a 
limited training of two 3-d courses for the residents, 
one basic and another for advanced training[294]. In 
Latin America, the project of Laparoscopia Avanzada 
Práctica (LAP), pretends to bring near a big number of 
countries to basic programs in laparoscopic training[295].
How does the resident get trained in laparoscopic 
surgery? The curricular model
One of the most important aspects of the residency 
program is that training has to be based in a curri-
cular model. Based on the premises that experts 
indicate[296], these curricula have to be: (1) Endorsed 
by an accredited training institution (ACS) with a clear 
message regarding how this surgical training will be; (2) 
If simulation is used as a training tool, this demands 
a new and different approach of the instructors; (3) 
Training has to be integrated with clinical practice; (4) 
Adequate simulators have to be used in the correct 
timing and they should be validated for training; (5) 
The features and different types of surgical simulators 
are continuously changing. This has to be taken 
into account in order to plan the update of these 
simulators; (6) Residents must have reserved time to 
use simulators in their training; and (7) Financing has 
to be sustainable using business principles.
How do surgical simulators contribute to laparoscopic 
training?
Virtual reality (VR) simulators provide surgical 
training without supervision in a safe environment for 
both patient and trainees. Skills obtained in the VR 
simulator can be transferred to the theatre. However, 
evidence is only limited to basic surgical skills and 
laparoscopic cholecystectomy. There is no evidence 
yet of the effect of VR simulators on advanced 
laparoscopic procedures[297]. The introduction of haptic 
feedback in these VR simulators has not increased the 
validation of laparoscopic surgical competences[298]. 
In summary, all the trails that compare the training 
using VR simulators and standard laparoscopic training 
in the theatre observe a higher performance after 
training with VR, confirming that current training using 
structured simulation is more efficient than traditional 
training[291]. Supported by these findings, countries 
such as Sweden or The Netherlands have established 
a structured training for laparoscopic cholecystectomy 
based in the use of VR simulators. This has allowed 
these countries validate resident competency before 
being trained in the theatre[299,300].
Animal models for resident training in advanced 
laparoscopic techniques (Nissen, Colectomy) are the 
more realistic models, but they are limited in some 
countries because of religious beliefs or laws. All these 
reasons are behind the substitution of these animals 
by synthetic models or even by simulated models with 
“ex vivo” viscera[301]. Without any doubt, the animal 
model most frequently used is the porcine model, 
mainly in colorectal surgery training[302]. Despite this, it 
is not possible to define nowadays when competency 
is reached with an animal model, if this model is the 
best one for laparoscopic training and if what is learned 
in this model is translated into clinical practice.
There are few studies about the use of cadaveric 
human models[303]. These models have been used for 
training in laparoscopic skills, such as cholecystectomy, 
and have demonstrated the increase of capacitation by 
comparison with VR simulators. We believe that this 
model has to be reserved for advanced laparoscopic 
procedures (colorectal or bariatric surgery) that require 
a huge degree of realism. Leblanc et al[304] assessed 
the use of fresh human cadavers for surgical training 
in laparoscopic sigmoidectomy. They observed that the 
use of this model improved clinical practice in terms 
of dissection, traction/counter traction, eye-hand 
coordination, suture, bleeding control and theatre 
time comparing with the use of a VR simulator. Palter 
et al[305] studied the sequencing of VR simulators 
with human cadaver models for training in colorectal 
laparoscopic surgery. He added a cognitive module 
in order to help the participants to understand the 
procedure and how to plan and execute a right 
colectomy or a sigmoidectomy. He observed that this 
training approach improved the technical knowledge 
and the performance in the theatre in comparison with 
the traditional training during the residency program. 
Hybrid models are those that use a complex 
robotized mannequin together with the abdomen/
thorax of a live animal. These models allow us a high 
laparoscopic realism simulation while we adjust the 
cardiologic/respiratory parameters of the robotized 
mannequin. This way we are able to simulate for 
example a coronary event during the simulated 
laparoscopic procedure.
In other opportunities[306], scenarios can be created 
to train the laparoscopic surgery team in a simulated 
theatre with a hybrid patient (SimMan 3G; Laerdal) 
and a laparoscopic VR simulator (Lap Mentor Express, 
Simbionix). These authors observed that the global 
assessment of the team showed a high qualification. 
Powers et al[307] observed that these simulation 
models let us discriminate between the technical and 
non-technical abilities in residents and experienced 
surgeons. The target of this innovative multidisciplinary 
simulation is to identify the problem and to start with 
the adequate solution by the surgical team. 
Zendejas et al[308] observed in a recent review that 
whenever simulator is used, it has huge advantages in 
laparoscopic or open surgery training comparing with 
no simulator use. These authors also observed that 
adding the use of simulators to the traditional training 
is more effective than the use of traditional training 
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alone.
Our model for laparoscopic surgery training for 
residents
Following the experience of authors such as Haluck et 
al[296], we think that the University Hospital Marqués 
de Valdecilla resident training meets a number of 
requirements[309]: (1) Our curriculum in laparoscopic 
procedures is developed during the full residency 
period. We think like Sadideen et al[310] that the first 
steps in surgical skill training have to be done outside 
the theatre and that practice is the most important 
thing to achieve automaticity in surgical skills. In the 
clinical environment, the needs of the patient prevail 
over the needs of the trainee; (2) The curriculum is 
compound by 19 laparoscopic modules; this allows 
the trainee to progressively gain competence as he 
learns. At the same time, each year modules are more 
technically advanced; (3) We support training in a 
simulated environment and advance in the learning 
curve during simulation. We have observed that doing 
gastrointestinal anastomosis and colonic resections 
this curve is shorter and increases patient safety[311]; (4) 
Working with the most realistic models in each training 
phase, we observed that an important part of the 
initial training can be performed with low cost animal 
“ex vivo” models. Some examples are gastrointestinal 
anastomosis, cholecystectomy or gastric bypass; (5) 
The modular curriculum covers not only technical skills 
competencies but also teamwork competencies during 
crisis in laparoscopic surgery procedures. Teamwork 
competencies are trained in hybrid simulators; (6) 
The training process of the resident is assessed with 
Global Rating Scales of Operative Performance. Even 
though we also apply this assessment to the clinical 
practice, it is very difficult to move this assessment 
to the professional competence[312]; and (7) The ACS 
accredits this training program and the center where it 
is developed.
We think that progress is very difficult and it may 
be necessary a trial/error system that let us advance. 
Learning from other programs that have tried, failed or 
succeeded may be a key point[313].
Current challenges of resident training in laparoscopic 
surgery
For most of the groups around the world, the most 
important challenge is defining how simulation based 
training can be implemented and improve the training 
system. There are many questions to be answered, as 
we cannot say with scientific evidence in which degree 
simulated training improves results or quality in clinical 
practice and patient safety.
Simulators have to improve their benefits and 
design, and objective measures have to be developed 
so we can say in which degree the trainee acquires the 
adequate clinical competencies that can be translated 
in to the theatre[314].
How can we keep and improve the acquired training 
during residency?
Mattar et al[315] observed that general surgery resi-
dency inadequately prepares trainees for fellowship 
results of a survey of fellowship program directors.
Fellowship programs are well established in 
countries such as the United States, Canada, United 
Kingdom or Australia. On the other hand, they have 
not had a good degree of implementation in the rest 
of Europe or in Eastern countries. These fellowship 
programs are advanced laparoscopic surgery training 
programs that have their own problems. Fellowships 
coexist with residency programs in the same institution 
and the continuous advance of new surgical techniques 
and the complexity of the surgical equipment make 
that some of the training is short in time or objectives. 
These reasons are making fellowships more and more 
specific as the recent fellowships in robotic colorectal 
surgery or rectal surgery is[316].
The development of national training programs 
in advanced laparoscopic surgery, such as the one 
developed in the United Kingdom[317] in laparoscopic 
colorectal surgery (Lapco) have shown good results in 
terms of short- and long-term training and have had a 
positive impact on the trainee learning curves[318,319]. 
There are an increasing number of short length 
training courses in advanced laparoscopic surgery. 
They are usually limited to 3-5 d and they include live 
procedures performed by expert surgeons in most of 
the cases. Some theoretical knowledge is also given 
either during the course or on-line and, in some 
cases, the trainees have the opportunity to practice 
the technique on an animal or cadaver model. These 
courses have been mostly developed in colorectal, 
bariatric and upper gastro-intestinal surgery. 
The impact of these courses on the training of the 
participant will depend on his previous experience 
in laparoscopic or open surgery. This way, we see 
that surgeons that come to a course with previous 
laparoscopic experience posteriorly implement 
the acquired knowledge during the course in a 
60%-70%. Without this experience the degree of 
implementation is under 25%[320,321]. Kinoshita et 
al[322] have demonstrated in Japan that after a training 
course in gastric laparoscopic surgery the number of 
laparoscopic gastrectomies increased in a 50% in the 
participating institutions. Participants answered to 
the survey saying that they felt improvement in their 
surgical skills in 100% of the initial procedures. On the 
other hand, Brunckhorst et al[323] say that there is very 
poor evidence concerning the training value of live 
operations and that very few high quality studies have 
been performed in this field. 
Our point of view is that these 3-5 d courses 
provide knowledge and skills that help the trainee in 
starting laparoscopic surgery in an already established 
unit. These courses also help surgeons in sharing 
experience with experts. 
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In summary, we can say that current literature 
consistently proves the positive impact of simulation in 
theatre time and the scores in predefined performance 
but, however, this is not enough to ensure the transfer 
of these lab acquired skills to the theatre. 
Which is the future of surgical training?
We are living a huge technological advance in all social 
scopes and also in surgical training[324]. In this context, 
the acquisition of knowledge is progressively moving 
to e-learning platforms that reduce classroom hours. 
This system includes interactive feedback with the 
instructor, assessment of the procedure and interaction 
with other participants. This system may also be 
combined with VR training[325].
VR simulators for laparoscopic surgery have been 
importantly improved with haptic technologies. In the 
near future, it may even be possible to import real 3D 
images to VR software. This may allow the trainees to 
perform real operations in virtual surgical fields that 
look like the real ones. Modelling this imported images, 
the trainee may even be able to work in fields with 
anatomical variations[326].
“Virtual cadavers” based on 3D images recon-
structed from computerized tomographies will replace 
human cadaver and animal models. It will be possible 
to create huge libraries with this “virtual cadavers”. 
The exposure to multiple scenarios during the same 
basic procedure will make easier the trainee progress 
from competency to expertise.
Tele-simulation will be possible thanks to this 
libraries allowing tele-training. Virtual environments as 
second life (SL) will be used to completely represent a 
training centre or meeting room. These environments 
are already available in the market and can make 
possible the interaction of scenarios, patients, VR 
simulators, lectures or videoclips. Surgeons will be able 
to build their own virtual clinic or whatever they may 
need to simulate according to the level of competency 
that is trained[327].
Tele-mentoring[328] using robots as RP-7 (RP-7, 
Intouch Health, Santa Barbara, California) makes 
possible active mentoring of the trainees with verbal 
instructions or changing position of the instruments/
camera when needed. It also makes possible a passive 
mentoring just with verbal instructions. This tele-
mentoring seems to be a valuable tool for training 
minimally invasive procedures. 
Now is the moment when all this separate tools, 
laparoscopic surgery, tele-presence, VR, digital image, 
networking… join together making tele-surgery 
possible. A surgeon is able to be miles away from the 
theatre and assist a surgical procedure.
Robotic surgery has been progressively incor-
porated to advanced laparoscopic procedures and has 
made those procedures easier. Robotics will facilitate 
the training of those surgical procedures. Mixing VR or 
virtual libraries with the surgical console of the robotic 
surgical systems will make it possible to train the 
procedure before doing it in the real world. It will make 
training a particular procedure in a particular patient 
possible.
In summary, we should imagine a surgeon being 
trained in his work environment in complex minimally 
invasive procedures by anther surgeon that is “on-line”. 
Robotic surgical systems will be present in daily work 
and training.
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